- Home
- RUN vs CLDX Comparison
RUN vs CLDX Comparison
Compare RUN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RUN | CLDX |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RUN | CLDX |
|---|---|---|
| Price | $11.43 | $35.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 10 |
| Target Price | $18.80 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 11.9M | 1.3M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 113.35 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $858,578,000.00 | $12,743,000.00 |
| Revenue This Year | $2.81 | $111.39 |
| Revenue Next Year | $4.54 | $235.85 |
| P/E Ratio | $18.54 | ★ N/A |
| Revenue Growth | 12.97 | ★ 87.78 |
| 52 Week Low | $9.01 | $19.72 |
| 52 Week High | $22.44 | $40.30 |
Technical Indicators
Market Signals| Indicator | RUN | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 38.14 | 50.95 |
| Support Level | N/A | $28.51 |
| Resistance Level | $21.01 | $40.30 |
| Average True Range (ATR) | 0.74 | 1.59 |
| MACD | -0.09 | -0.51 |
| Stochastic Oscillator | 12.13 | 25.89 |
Price Performance
Historical ComparisonAbout RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.